BBIO
Overvalued by 129.9% based on the discounted cash flow analysis.
Market cap | $5.81 Billion |
---|---|
Enterprise Value | $7.00 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-3.18 |
Beta | 2.08 |
Outstanding Shares | 187,129,260 |
Avg 30 Day Volume | 1,513,165 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -10.79 |
---|---|
PEG | 14.41 |
Price to Sales | 30.09 |
Price to Book Ratio | -5.02 |
Enterprise Value to Revenue | 32.04 |
Enterprise Value to EBIT | -14.81 |
Enterprise Value to Net Income | -14 |
Total Debt to Enterprise | 0.24 |
Debt to Equity | -1.63 |
No data
No data